Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 6:23 PM ET

Healthcare Equipment and Supplies

Company Overview of VisionCare Ophthalmic Technologies, Inc.

Company Overview

VisionCare Ophthalmic Technologies, Inc. develops, manufactures, and markets visual prosthetic ophthalmic devices and technologies for individuals with age-related macular degeneration. It offers Implantable Miniature Telescope, a visual prosthetic device designed to improve the vision of patients with bilateral moderate to severe central vision loss due to age-related macular degeneration and other macular disorders. The company was founded in 1997 and is based in Saratoga, California.

14395 Saratoga Avenue

Suite 150

Saratoga, CA 95070

United States

Founded in 1997





Key Executives for VisionCare Ophthalmic Technologies, Inc.

Chief Executive Officer and President
Chairman and Advisor
Age: 65
Vice President of Finance & Administration
Compensation as of Fiscal Year 2015.

VisionCare Ophthalmic Technologies, Inc. Key Developments

VisionCare Ophthalmic Technologies Announces Executive Appointments

VisionCare Ophthalmic Technologies announced the appointments of Blake Michaels as Vice President, Sales and current executive, Chet Kumar, as Vice President, Corporate Development and Innovation. Mr. Michaels was most recently Director of Key Accounts for Alcon Laboratories (Novartis).

VisionCare Ophthalmic Technologies, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-11-2015 04:15 PM

VisionCare Ophthalmic Technologies, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-11-2015 04:15 PM. Venue: Le Parker Meridian, 119 West 56th Street, New York, NY 10019, United States.

Visioncare Ophthalmic Technologies Announces Executive Changes

VisionCare Ophthalmic Technologies announced that Wolfgang Tolle will join the company as President and Chief Executive Officer. VisionCare's current CEO, Allen Hill, will turn over duties effective May 1, 2015 and transition to Chairman & Advisor. He was most recently President & COO of PostCreator. From 2011 to 2014, Mr. Tolle was General Manager of Alcon Benelux (Belgium, Netherlands, and Luxemburg) where he was responsible for all Alcon product lines including surgical, pharmaceutical, and contact lenses.

Similar Private Companies By Industry

Company Name Region
CardioDx, Inc. United States
Moximed, Inc. United States
Pro Med Instruments, Inc. United States
Aerin Medical, Inc. United States
DgR, Inc. United States

Recent Private Companies Transactions

Private Placement
December 16, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact VisionCare Ophthalmic Technologies, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at